BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37959715)

  • 21. Characterization of albendazole-randomly methylated-β-cyclodextrin inclusion complex and in vivo evaluation of its antihelmitic activity in a murine model of Trichinellosis.
    García A; Leonardi D; Vasconi MD; Hinrichsen LI; Lamas MC
    PLoS One; 2014; 9(11):e113296. PubMed ID: 25406084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. (13)C and (15)N solid-state NMR studies on albendazole and cyclodextrin albendazole complexes.
    Ferreira MJ; García A; Leonardi D; Salomon CJ; Lamas MC; Nunes TG
    Carbohydr Polym; 2015 Jun; 123():130-5. PubMed ID: 25843843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Albendazole nanocrystals with improved pharmacokinetic performance in mice.
    Paredes AJ; Bruni SS; Allemandi D; Lanusse C; Palma SD
    Ther Deliv; 2018 Feb; 9(2):89-97. PubMed ID: 29325510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dissolution/Permeation of Albendazole in the Presence of Cyclodextrin and Bile Salts: A Mechanistic In Vitro Study into Factors Governing Oral Bioavailability.
    Eriksen JB; Christensen SB; Bauer-Brandl A; Brandl M
    J Pharm Sci; 2022 Jun; 111(6):1667-1673. PubMed ID: 34808218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioavailability comparison between albendazole and albendazole sulphoxide in rats and man.
    Dominguez L; Fagiolino P; Gordon S; Manta E
    Farmaco; 1995 Oct; 50(10):697-702. PubMed ID: 8590577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disposition kinetics of albendazole and metabolites in laying hens.
    Bistoletti M; Alvarez L; Lanusse C; Moreno L
    J Vet Pharmacol Ther; 2013 Apr; 36(2):161-8. PubMed ID: 22533477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative plasma disposition kinetics of albendazole and its new benzimidazol prodrug in dog.
    Khalil Z; El Karbane M; Faouzi ME; Ansar M; Azougagh M; El Harti J; Taoufik J
    Ann Pharm Fr; 2016 Jan; 74(1):21-6. PubMed ID: 26530448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thymol/cyclodextrin inclusion complex nanofibrous webs: Enhanced water solubility, high thermal stability and antioxidant property of thymol.
    Celebioglu A; Yildiz ZI; Uyar T
    Food Res Int; 2018 Apr; 106():280-290. PubMed ID: 29579928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ex vivo diffusion of albendazole and its sulfoxide metabolite into ascaris suum and Fasciola hepatica.
    Alvarez LI; Mottier ML; Sánchez SF; Lanusse CE
    Parasitol Res; 2001 Nov; 87(11):929-34. PubMed ID: 11728018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hydroxypropyl-beta-cyclodextrin-flutamide inclusion complex. II. Oral and intravenous pharmacokinetics of flutamide in the rat.
    Zuo Z; Tam YK; Diakur J; Wiebe LI
    J Pharm Pharm Sci; 2002; 5(3):292-8. PubMed ID: 12553899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In Vitro and In Vivo Drug Interaction Study of Two Lead Combinations, Oxantel Pamoate plus Albendazole and Albendazole plus Mebendazole, for the Treatment of Soil-Transmitted Helminthiasis.
    Cowan N; Vargas M; Keiser J
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6127-33. PubMed ID: 27480864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioavailability of albendazole sulphoxide after netobimin administration in sheep: effects of fenbendazole coadministration.
    Merino G; Alvarez AI; Redondo PA; Garcia JL; Larrodé OM; Prieto JG
    Res Vet Sci; 1999 Jun; 66(3):281-3. PubMed ID: 10333473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of cyclodextrin inclusion complexes of the anti-HIV non-nucleoside reverse transcriptase inhibitor UC781.
    Yang H; Parniak MA; Isaacs CE; Hillier SL; Rohan LC
    AAPS J; 2008 Dec; 10(4):606-13. PubMed ID: 19089644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclodextrin inclusion complex of racecadotril: effect of drug-β- cyclodextrin ratio and the method of complexation.
    Semalty M; Panchpuri M; Singh D; Semalty A
    Curr Drug Discov Technol; 2014 Jun; 11(2):154-61. PubMed ID: 24188445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A nanocrystal-based formulation improves the pharmacokinetic performance and therapeutic response of albendazole in dogs.
    Paredes AJ; Litterio N; Dib A; Allemandi DA; Lanusse C; Bruni SS; Palma SD
    J Pharm Pharmacol; 2018 Jan; 70(1):51-58. PubMed ID: 29034951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation and in vitro studies on radioactive and nonradioactive albendazole-beta-cyclodextrin complex tablets.
    Cetin EO; Ilem D; Gundogdu E; Asikoglu M; Kirilmaz L
    Pharmazie; 2011 Sep; 66(9):672-6. PubMed ID: 22026122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and Pharmacokinetic Evaluation of Two Parenteral Formulations of Albendazole Using Prodrug and Cosolvent Approaches.
    Becerril-Vega J; Hernández-Campos A; González-Hernández I; Flores-Ramos M; Castillo R; Leyva-Gómez G; Mayet-Cruz L; Jung-Cook H
    AAPS PharmSciTech; 2023 Jul; 24(6):158. PubMed ID: 37498473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enantioselective analysis of albendazole sulfoxide in cerebrospinal fluid by capillary electrophoresis.
    Paias FO; Lanchote VL; Takayanagui OM; Bonato PS
    Electrophoresis; 2001 Sep; 22(15):3263-9. PubMed ID: 11589289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hydroxy-Propil-β-Cyclodextrin Inclusion Complexes of two Biphenylnicotinamide Derivatives: Formulation and Anti-Proliferative Activity Evaluation in Pancreatic Cancer Cell Models.
    Iacobazzi RM; Cutrignelli A; Stefanachi A; Porcelli L; Lopedota AA; Di Fonte R; Lopalco A; Serratì S; Laquintana V; Silvestris N; Franco M; Cellamare S; Leonetti F; Azzariti A; Denora N
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32906812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic interaction between albendazole sulfoxide enantiomers and antiepileptic drugs in patients with neurocysticercosis.
    Lanchote VL; Garcia FS; Dreossi SA; Takayanagui OM
    Ther Drug Monit; 2002 Jun; 24(3):338-45. PubMed ID: 12021623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.